PFSA Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-384.070.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$561800Micro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- 104.68
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 0.44
Last earnings
Apr 1, 2026 · Reported $-51.18
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Profusa, Inc. Common Stock
Company profileProfusa, Inc. develops bioengineered sensors that are designed to become one with the body to detect and continuously transmit clinical -grade data for personal and medical use. The company is headquartered in Emeryville, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 626 BANCROFT WAY, BERKELEY, CA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$561800
Shares outstanding$530000
52W high$1,297.50
52W low$0.86
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent